Four-Year Experience With Extracorporeal Membrane Oxygenation for Kidney Transplant Patients With Severe Refractory Cardiopulmonary Insufficiency.

•Because of their immunosuppressive treatments, kidney transplant recipients are vulnerable to infections, and these patients occasionally experience serious acute cardiopulmonary dysfunction.•Extracorporeal membrane oxygenation (ECMO) can be a beneficial rescue therapy in immunosuppressed patients with cardiopulmonary dysfunction refractory to conventional treatment.•Severe acidosis before the administration of EMCO is identified as a risk factor for ECMO weaning failure.